Published in Vaccine Weekly, April 16th, 2003
"The mite protein Der p 1 is a major trigger of allergy and atopic asthma worldwide, and thus, a good vaccine candidate for allergy prevention. Since it is a cysteine protease, the catalytic effects of Der p 1 vaccination may be unpredictable. One approach to reduce this risk is to vaccinate with DNA encoding enzymatically inactive forms of Der p 1," said C.B. Wolfowicz and colleagues.
In their study, "... Der p 1 DNA without its native pre-pro sequences potently induced Der p 1-specific...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-04-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.